MGEN - miRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2020 Results - Earnings Call Transcript
miRagen Therapeutics, Inc. (MGEN)
Q2 2020 Earnings Conference Call
August 5, 2020 4:30 PM ET
Company Participants
Dan Ferry – Managing Director-LifeSci Advisors
Bill Marshall – President and Chief Executive Officer
Diana Escolar – Chief Medical Officer
Jason Leverone – Chief Financial Officer
Conference Call Participants
Jonathan Miller – Evercore ISI
Andreas Argyrides – Wedbush Securities
Trevor Allred – Oppenheimer
Presentation
Operator
Greetings, and welcome to the miRagen Therapeutics Q2 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As